GLMD
Galmed Pharmaceuticals Ltd
NASDAQ: GLMD · HEALTHCARE · BIOTECHNOLOGY
$0.56
-4.92% today
Updated 2026-04-29
Market cap
$4.12M
P/E ratio
—
P/S ratio
61.38x
EPS (TTM)
$-2.39
Dividend yield
—
52W range
$0 – $2
Volume
3.7M
Galmed Pharmaceuticals Ltd (GLMD) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-10.4%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-18.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+11.3%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+14.4%
2025-11-26
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-01 | $-0.73 | -43.5% | $0.49 | $0.54 | +10.2% |
| 2025-12-31 | $-0.92 | -80.4% | $0.75 | $0.82 | +9.2% |
| 2025-11-26 | $-0.33 | +58.2% | $0.82 | $0.94 | +14.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.51 | $-0.73 | -43.5% | — | — |
| 2025-12-31 | $-0.51 | $-0.92 | -80.4% | — | — |
| 2025-09-30 | $-0.79 | $-0.33 | +58.2% | — | — |
| 2025-06-30 | $-0.83 | $-0.63 | +24.1% | — | — |
| 2025-03-31 | $-0.89 | $-0.62 | +30.3% | — | — |
| 2024-12-31 | — | $-1.94 | — | — | — |
| 2024-09-30 | — | $-2.31 | — | — | — |
| 2024-06-30 | — | $-2.13 | — | — | — |
| 2024-03-31 | $-0.32 | $-0.98 | -206.2% | — | — |
| 2023-12-31 | $-0.32 | $-0.98 | -206.2% | — | — |
| 2023-09-30 | $-0.27 | $-0.24 | +11.1% | — | — |
Frequently asked questions
Has Galmed Pharmaceuticals Ltd beaten earnings estimates?
Galmed Pharmaceuticals Ltd has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -10.4% over the last 4 quarters.
How does GLMD stock react to earnings?
GLMD stock has moved an average of +11.3% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.